Vaccine-associated enhanced respiratory disease is influenced by haemagglutinin and neuraminidase in whole inactivated influenza virus vaccines

Journal of General Virology

Volumn 97, Issue 7, 2016, Pages 1489-1499

  Rajão, Daniela S ^a   Chen, Hongjun ^b   Perez, Daniel R ^b,e   Sandbulte, Matthew R ^c,f   Gauger, Phillip C ^c   Loving, Crystal L ^a   Dennis Shanks, G ^d   Vincent, Amy ^a  

^a NATIONAL ANIMAL DISEASE CENTER   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c IOWA STATE UNIVERSITY   (United States)

^d AUSTRALIAN ARMY MALARIA INSTITUTE   (Australia)

^e UNIVERSITY OF GEORGIA   (United States)

^f Merck Animal Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; COMPLEMENT FIXING ANTIBODY; IMMUNOGLOBULIN G; INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; VIRUS NUCLEOPROTEIN; VIRUS SIALIDASE; INACTIVATED VACCINE; NEUTRALIZING ANTIBODY; NUCLEOPROTEIN; SIALIDASE; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CROSS REACTION; ENZYME LINKED IMMUNOSPOT ASSAY; IMMUNE RESPONSE; INFLUENZA; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H1N2); INFLUENZA VACCINATION; LUNG; NONHUMAN; PIG; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVERSE ENGINEERING; TRACHEA; VACCINE ASSOCIATED ENHANCED RESPIRATORY DISEASE; VIRUS REPLICATION; VIRUS SHEDDING; ANIMAL; IMMUNOLOGY; INFLUENZA A VIRUS (H3N2); ORTHOMYXOVIRIDAE INFECTIONS; RESPIRATORY SYSTEM; SWINE DISEASES; VACCINATION; VIROLOGY;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H1N2 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; NEURAMINIDASE; NUCLEOPROTEINS; ORTHOMYXOVIRIDAE INFECTIONS; RESPIRATORY SYSTEM; SWINE; SWINE DISEASES; VACCINATION; VACCINES, INACTIVATED;

EID: 84977554467     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/jgv.0.000468     Document Type: Article

References (46)

1. Korslund, J. A. & Vincent, A. L. (2013). Population dynamics of cocirculating swine influenza A viruses in the United States from 2009 to 2012. Influenza Other Respir Viruses 7, 42-51.
2. Assarsson, E., Bui, H. H., Sidney, J., Zhang, Q., Glenn, J., Oseroff, C., Mbawuike, I. N., Alexander, J., Newman, M. J. & other authors (2008). Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans. J Virol 82, 12241-12251.
3. Constantine, N. & Lana, D. (2003). Immunoassays for the diagnosis of infectious diseases. In Manual of Clinical Microbiology, 8th edn, pp. 218-233. Edited by P. R. Murray. Washington, DC: ASM Press.
4. Gauger, P. C. & Vincent, A. L. (2014). Serum virus neutralization assay for detection and quantitation of serum-neutralizing antibodies to influenza A virus in swine. In Animal Influenza Virus, pp. 313-324. Edited by E. Spackman. New York, NY: Springer.
5. Gauger, P. C., Vincent, A. L., Loving, C. L., Lager, K. M., Janke, B. H., Kehrli, M. E. & Roth, J. A. (2011). Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (delta-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus. Vaccine 29, 2712-2719.
6. Gauger, P. C., Vincent, A. L., Loving, C. L., Henningson, J. N., Lager, K. M., Janke, B. H., Kehrli, M. E. & Roth, J. A. (2012). Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A/H1N1 influenza virus. Vet Pathol 49, 900-912.
7. Gras, S., Kedzierski, L., Valkenburg, S. A., Laurie, K., Liu, Y. C., Denholm, J. T., Richards, M. J., Rimmelzwaan, G. F., Kelso, A. & other authors (2010). Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses. Proc Natl Acad Sci U S A 107, 12599-12604.
8. Halbur, P. G., Paul, P. S., Frey, M. L., Landgraf, J., Eernisse, K., Meng, X. J., Lum, M. A., Andrews, J. J. & Rathje, J. A. (1995). Comparison of the pathogenicity of two US porcine reproductive and respiratory syndrome virus isolates with that of the Lelystad virus. Vet Pathol 32, 648-660.
9. Halstead, S. B. & O’Rourke, E. J. (1977). Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med 146, 201-217.
10. Hoffmann, E., Neumann, G., Kawaoka, Y., Hobom, G. & Webster, R. G. (2000). A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A 97, 6108-6113.
11. Howden, K. J., Brockhoff, E. J., Caya, F. D., McLeod, L. J., Lavoie, M., Ing, J. D., Bystrom, J. M., Alexandersen, S., Pasick, J. M. & other authors (2009). An investigation into human pandemic influenza virus (H1N1) 2009 on an Alberta swine farm. Can Vet J 50, 1153-1161.
12. Janke, B. H. (2013). Clinicopathological features of Swine influenza. In Swine Influenza, pp. 69-83. Edited by J. A. Richt & R. J. Webby. Berlin/Heidelberg, DE: Springer.
13. Jegaskanda, S., Job, E. R., Kramski, M., Laurie, K., Isitman, G., de Rose, R., Winnall, W. R., Stratov, I., Brooks, A. G. & other authors (2013). Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies. J Immunol 190, 1837-1848.
14. Jegaskanda, S., Reading, P. C. & Kent, S. J. (2014). Influenza-specific antibody-dependent cellular cytotoxicity: toward a universal influenza vaccine. J Immunol 193, 469-475.
15. Johansson, B. E. & Cox, M. M. (2011). Influenza viral neuraminidase: the forgotten antigen. Expert Rev Vaccines 10, 1683-1695.
16. Khurana, S., Loving, C. L., Manischewitz, J., King, L. R., Gauger, P. C., Henningson, J., Vincent, A. L. & Golding, H. (2013). Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease. Sci Transl Med 5, 200ra114.
17. Kitikoon, P., Nilubol, D., Erickson, B. J., Janke, B. H., Hoover, T. C., Sornsen, S. A. & Thacker, E. L. (2006). The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination. Vet Immunol Immunopathol 112, 117-128.
18. Lambré, C. R., Terzidis, H., Greffard, A. & Webster, R. G. (1990). Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates. J Immunol Methods 135, 49-57.
19. Marcelin, G., Sandbulte, M. R. & Webby, R. J. (2012). Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines. Rev Med Virol 22, 267-279.
20. Monsalvo, A. C., Batalle, J. P., Lopez, M. F., Krause, J. C., Klemenc, J., Hernandez, J. Z., Maskin, B., Bugna, J., Rubinstein, C. & other authors (2011). Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat Med 17, 195-199.
21. Murphy, B. R., Prince, G. A., Walsh, E. E., Kim, H. W., Parrott, R. H., Hemming, V. G., Rodriguez, W. J. & Chanock, R. M. (1986). Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine. J Clin Microbiol 24, 197-202.
22. Nelson, M. I., Vincent, A. L., Kitikoon, P., Holmes, E. C. & Gramer, M. R. (2012). Evolution of novel reassortant A/H3N2 influenza viruses in North American swine and humans, 2009-2011. J Virol 86, 8872-8878.
23. O’Brien, K. B., Morrison, T. E., Dundore, D. Y., Heise, M. T. & Schultz-Cherry, S. (2011). A protective role for complement C3 protein during pandemic 2009 H1N1 and H5N1 influenza A virus infection. PLoS One 6, e17377.
24. Parzych, E. M., DiMenna, L. J., Latimer, B. P., Small, J. C., Kannan, S., Manson, B., Lasaro, M. O., Wherry, E. J. & Ertl, H. C. (2013). Influenza virus specific CD8(+) T cells exacerbate infection following high dose influenza challenge of aged mice. Biomed Res Int 2013, 876314.
25. Pena, L., Vincent, A. L., Ye, J., Ciacci-Zanella, J. R., Angel, M., Lorusso, A., Gauger, P. C., Janke, B. H., Loving, C. L. & other authors (2011). Modifications in the polymerase genes of a swine-like triplereassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses. J Virol 85, 456-469.
26. Perrone, L. A., Plowden, J. K., García-Sastre, A., Katz, J. M. & Tumpey, T. M. (2008). H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog 4, e1000115.
27. Rajão, D. S., Loving, C. L., Gauger, P. C., Kitikoon, P. & Vincent, A. L. (2014). Influenza A virus hemagglutinin protein subunit vaccine elicits vaccine-associated enhanced respiratory disease in pigs. Vaccine 32, 5170-5176.
28. Reed, l. J. & Muench, H. (1938). A simple method of estimating fifty per cent endpoints. Am J Epidemiol 27, 493-497.
29. Rott, R., Becht, H. & Orlich, M. (1974). The significance of influenza virus neuraminidase in immunity. J Gen Virol 22, 35-41.
30. Sandbulte, M. R. & Eichelberger, M. C. (2014). Analyzing swine sera for functional antibody titers against influenza A neuraminidase proteins using an enzyme-linked lectin assay (ELLA). Methods Mol Biol 1161, 337-345.
31. Shanks, G. D. & Brundage, J. F. (2012). Pathogenic responses among young adults during the 1918 influenza pandemic. Emerg Infect Dis 18, 201-207.
32. Skowronski, D. M., De Serres, G., Crowcroft, N. S., Janjua, N. Z., Boulianne, N., Hottes, T. S., Rosella, L. C., Dickinson, J. A., Gilca, R. & other authors (2010). Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during spring-summer 2009: Four observational studies from Canada. PLoS Med 7, e1000258.
33. Sylte, M. J. & Suarez, D. L. (2009). Influenza neuraminidase as a vaccine antigen. Curr Top Microbiol Immunol 333, 227-241.
34. Tamura, K., Stecher, G., Peterson, D., Filipski, A. & Kumar, S. (2013). MEGA6: Molecular evolutionary genetics analysis version 6.0. Mol Biol Evol 30, 2725-2729.
35. Tang, Y., Lee, C. W., Zhang, Y., Senne, D. A., Dearth, R., Byrum, B., Perez, D. R., Suarez, D. L. & Saif, Y. M. (2005). Isolation and characterization of H3N2 influenza A virus from Turkeys. Avian Dis 49, 207-213.
36. Taubenberger, J. K. & Morens, D. M. (2006). 1918 influenza: the mother of all pandemics. Emerg Infect Dis 12, 15-22.
37. To, K. K., Zhang, A. J., Hung, I. F., Xu, T., Ip, W. C., Wong, R. T., Ng, J. C., Chan, J. F., Chan, K. H. & other authors. (2012). High titer and avidity of nonneutralizing antibodies against influenza vaccine antigen are associated with severe influenza. Clin Vaccine Immunol 19, 1012-1018.
38. Van Reeth, K., Nauwynck, H. & Pensaert, M. (1998). Bronchoalveolar interferon-alpha, tumor necrosis factor-alpha, interleukin-1, and inflammation during acute influenza in pigs: a apossible model for humans? J Infect Dis 177, 1076-1079.
39. Vincent, A. L., Lager, K. M., Janke, B. H., Gramer, M. R. & Richt, J. A. (2008a). Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine. Vet Microbiol 126, 310-323.
40. Vincent, A. L., Ma, W., Lager, K. M., Janke, B. H. & Richt, J. A. (2008b). Swine influenza viruses: a North American perspective. In Adv Virus Res, pp. 127-154. Edited by K Maramorosch, A. J. Shatkin & F. A. Murphy. Burlington, MA: Academic Press.
41. Vincent, A. L., Ma, W., Lager, K. M., Gramer, M. R., Richt, J. A. & Janke, B. H. (2009). Characterization of a newly emerged genetic cluster of H1N1 and H1N2 swine influenza virus in the United States. Virus Genes 39, 176-185.
42. Vincent, A. L., Ma, W., Lager, K. M., Richt, J. A., Janke, B. H., Sandbulte, M. R., Gauger, P. C., Loving, C. L., Webby, R. J. & other authors (2012). Live attenuated influenza vaccine provides superior protection from heterologous infection in pigs with maternal antibodies without inducing vaccine-associated enhanced respiratory disease. J Virol 86, 10597-10605.
43. Wan, H., Sorrell, E. M., Song, H., Hossain, M. J., Ramirez-Nieto, G., Monne, I., Stevens, J., Cattoli, G., Capua, I. & other authors (2008). Replication and transmission of H9N2 influenza viruses in ferrets: evaluation of pandemic potential. PLoS One 3, e2923.
44. Wiley, J. A., Cerwenka, A., Harkema, J. R., Dutton, R. W. & Harmsen, A. G. (2001). Production of interferon-gamma by influenza hemagglutinin-specific CD8 effector T cells influences the development of pulmonary immunopathology. Am J Pathol 158, 119-130.
45. World Health Organization (2002). WHO Manual on Animal Influenza Diagnosis and Surveillance, 2nd edn, Geneva.
46. Worobey, M., Han, G. Z. & Rambaut, A. (2014). Genesis and pathogenesis of the 1918 pandemic H1N1 influenza A virus. Proc Natl Acad Sci U S A 111, 8107-8112.